JOSEPH MORRIS: Open Payments
NPI 1578290748 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $556 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| Indivior Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, SUBLOCADE, TRINTELLIX, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, REXULTI.
Industry payments across CA — which companies pay providers there.
